Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 9/20 | 0.42 |
| ▸ | DDB1 | Q16531 | 3/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.37 |
| ▸ | CYP11A1 | P05108 | 1/20 | 0.37 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.37 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10456597 | 0.77 | — | — | |
| SCHEMBL83187 | 0.77 | CRBN (0.44) | CRBNCYP19A1CYP3A4CYP17A1CYP11A1 | |
| SCHEMBL21026707 | 0.73 | CRBN (0.45) | CRBNCYP19A1CYP3A4CYP17A1CYP11A1 | |
| SCHEMBL21848668 | 0.73 | CRBN (0.41) | CRBNCYP19A1CYP3A4CYP17A1CYP11A1 | |
| SCHEMBL17169743 | 0.73 | CRBN (0.41) | CRBNCYP19A1CYP3A4CYP17A1CYP11A1 | |
| SCHEMBL23939159 | 0.73 | CRBN (0.41) | CRBNDDB1CYP19A1CYP3A4CYP17A1 | |
| SCHEMBL8259939 | 0.73 | CRBN (0.41) | CRBNCYP19A1CYP3A4CYP17A1CYP11A1 | |
| SCHEMBL19310106 | 0.73 | CRBN (0.41) | CRBNCYP19A1CYP3A4CYP17A1CYP11A1 | |
| SCHEMBL632775 | 0.73 | CRBN (0.41) | CRBNCYP19A1CYP3A4CYP17A1CYP11A1 | |
| SCHEMBL23545935 | 0.73 | CYP19A1 (0.44) | CRBNDDB1CYP19A1CYP3A4CYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3643709-B1 | ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | KANGPU BIOPHARMACEUTICALS LTD (CN) | 2021-10-20 | — | — | EP | disclosed |
| EP-3643709-A1 | ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | Kangpu Biopharmaceuticals, Ltd. (CN) | 2020-04-29 | — | — | EP | disclosed |
| EP-3581182-A2 | COMBINATION TREATING PROSTATE CANCER, PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD | Kangpu Biopharmaceuticals, Ltd. (CN) | 2019-12-18 | — | — | EP | disclosed |